|
Status |
Public on Jan 16, 2011 |
Title |
Sample050620621-African American-Case |
Sample type |
RNA |
|
|
Source name |
Plasma
|
Organism |
Homo sapiens |
Characteristics |
race: African American disease state: early stage breast cancer tissue: plasma
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA, including miRNA from plasma, was isolated using the miRNeasy kit (Qiagen) with minor modifications. The quality and quantity of the RNA was evaluated by 260/280 ratio using NanoDrop spectrophotometry (NanoDrop ND-1000 Technologies Inc.) and Agilent 2100 Bioanalyzer (Agilent Technologies).
|
Label |
biotin
|
Label protocol |
Two hundred ng of total RNA from each sample were labeled and hybridized on Human v2 MicroRNA Expression BeadChips (Cat. no. MI-102–1024; Illumina), according to the manufacturers recommendations (Illumina MicroRNA Expression Profiling Assay Guide).
|
|
|
Hybridization protocol |
Two hundred ng of total RNA from each sample were labeled and hybridized on Human v2 MicroRNA Expression BeadChips (Cat. no. MI-102–1024; Illumina), according to the manufacturers recommendations (Illumina MicroRNA Expression Profiling Assay Guide).
|
Scan protocol |
Standard Illumina scanning protocol
|
Description |
50620621
|
Data processing |
The data were normalised using quantile normalisation with lumi package in R
|
|
|
Submission date |
Jul 16, 2010 |
Last update date |
Jan 16, 2011 |
Contact name |
hua zhao |
E-mail(s) |
Hua.Zhao@RoswellPark.org
|
Organization name |
Roswell Park Cancer Institute
|
Street address |
Elm and Carlton Streets
|
City |
Buffalo |
State/province |
NY |
ZIP/Postal code |
14263 |
Country |
USA |
|
|
Platform ID |
GPL8179 |
Series (1) |
GSE22981 |
Circulating miRNAs as biomarkers and potential functional mediators of early stage breast cancer |
|